Label: LORAZEPAM tablet
- NDC Code(s): 70518-1520-0, 70518-1520-1, 70518-1520-2, 70518-1520-3, view more
- Packager: REMEDYREPACK INC.
- This is a repackaged label.
- Source NDC Code(s): 69315-904
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: CIV
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated April 17, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Medication Guide: HTML
- Official Label (Printer Friendly)
-
BOXED WARNING
(What is this?)
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
- Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation (see WARNINGSand PRECAUTIONS).
- The use of benzodiazepines, including lorazepam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing lorazepam and throughout treatment, assess each patient’s risk for abuse, misuse, and addiction (see WARNINGS).
- The continued use of benzodiazepines, including lorazepam may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Abrupt discontinuation or rapid dosage reduction of lorazepam after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue lorazepam or reduce the dosage ( DOSAGE AND ADMINISTRATIONand WARNINGS).
-
DESCRIPTIONLorazepam, an antianxiety agent, has the chemical formula, 7-chloro-5-( o-chlorophenyl)-1,3-dihydro-3-hydroxy-2 - H-1,4-benzodiazepin-2-one: It is a nearly white powder almost ...
-
CLINICAL PHARMACOLOGYStudies in healthy volunteers show that in single high doses lorazepam has a tranquilizing action on the central nervous system with no appreciable effect on the respiratory or cardiovascular ...
-
INDICATIONS AND USAGELorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated ...
-
CONTRAINDICATIONSLorazepam is contraindicated in patients with: hypersensitivity to benzodiazepines or to any components of the formulation - acute narrow-angle glaucoma.
-
WARNINGSRisks from Concomitant Use with Opioids - Concomitant use of benzodiazepines, including Lorazepam, and opioids may result in profound sedation, respiratory depression, coma, and death. Because of ...
-
PRECAUTIONSIn patients with depression, a possibility for suicide should be borne in mind; benzodiazepines should not be used in such patients without adequate antidepressant therapy. Lorazepam should be ...
-
ADVERSE REACTIONSMost adverse reactions to benzodiazepines, including CNS effects and respiratory depression, are dose dependent, with more severe effects occurring with high doses. In a sample of about 3500 ...
-
DRUG ABUSE AND DEPENDENCEControlled Substance - Lorazepam contains lorazepam, a Schedule IV controlled substance. Abuse - Lorazepam is a benzodiazepine and a CNS depressant with a potential for abuse and addiction ...
-
OVERDOSAGEOverdosage of benzodiazepines is characterized by central nervous system depression ranging from drowsiness to coma. In mild to moderate cases, symptoms can include drowsiness, confusion ...
-
DOSAGE AND ADMINISTRATIONLorazepam is administered orally. For optimal results, dose, frequency of administration, and duration of therapy should be individualized according to patient response. To facilitate this, 0.5 ...
-
HOW SUPPLIEDLorazepam® (lorazepam) Tablets are available in the following dosage strengths: 0.5 mg White color, round, flat face beveled edge compressed tablets, debossed "EP" and "904" on one side, and plain ...
-
SPL UNCLASSIFIED SECTIONRepackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762
-
MEDICATION GUIDE
Lorazepam Tablets, CIV
(lor az' e pam)
What is the most important information I should know about lorazepam tablets? Lorazepam tablets are a benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other ...
-
PRINCIPAL DISPLAY PANELDRUG: Lorazepam - GENERIC: Lorazepam - DOSAGE: TABLET - ADMINSTRATION: ORAL - NDC: 70518-1520-0 - NDC: 70518-1520-1 - NDC: 70518-1520-2 - NDC: 70518-1520-3 - NDC: 70518-1520-4 - NDC: 70518-1520-5 - COLOR: white - SHAPE ...
-
INGREDIENTS AND APPEARANCEProduct Information